Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

The antigen-binding site of the antibody has ... demonstrating broad neutralization against the latest SARS-CoV-2 variants and related sarbecoviruses. Follicular regulatory T (Tfr) cells modulate ...

Neutralization test is one tool used for serodiagnosis ... using the nucleocapsid-recombinant protein of Araraquara virus (ARAV) as antigen, allows to detect, in 10–15 min, antihantavirus ...

Next-Generation Immunomodulators BNT327 is a bispecific antibody candidate combining PD-L1 checkpoint inhibition with VEGF-A neutralization ... and encodes four melanoma-associated antigens. BioNTech ...

Analyzing the humoral and cellular immune system in fully vaccinated HCWs - on the other side - showed elevated humoral response to SARS CoV-2, both SARS-CoV-2 IgG-Ab (S1) and SARS CoV-2 surrogate ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

As part of the Russian Firepower Strike Tracker, this commentary uses data science to analyze the correlates of neutralization. Specifically, researchers in the CSIS Futures Lab show that it is not ...

Recipient T cells recognize donor antigens via two distinct pathways: the direct pathway (intact donor MHC molecules displayed on donor antigen-presenting cells [APCs]) and the indirect pathway ...

The rarest blood type is Rhnull. Unlike other blood types, people with Rhnull blood have no Rh antigens on their red blood cells. Healthcare professionals classify blood type according to the ...

Antibodies have become the Swiss Army tool for molecular biology and nanotechnology. Their outstanding ability to specifically recognise molecular antigens allows their use in many different ...

Specifically, Auletta highlights the emerging science in stem cell transplants and cell therapies, including treatments like chimeric antigen receptor (CAR) T-cell therapy. He also discussed topics ...